ezetimibe has been researched along with Gallstones in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, A; Hu, H; Jiang, Z; Shao, W; Shen, W; Wang, B; Wang, Q; Zhao, G | 1 |
| Fu, Z; Han, T; Hong, H; Hu, T; Lv, Y; Wang, S | 1 |
| Arrese, M; Bizama, C; Espinoza, JA; Ferreccio, C; García, P; Gómez, N; González, X; Guevara, F; Kalergis, AM; Lobos-González, L; Miquel, JF; Muñoz-Durango, N; Roa, JC; Rosa, L; Saavedra, N; Villegas, J; Wichmann, IA | 1 |
| Desai, S; E, S; Gangadharappa, HV; Krishna, KL; Mehdi, S; Shreyas, A; Srikanth, MS | 1 |
| de Bari, O; Garruti, G; Liu, KJ; Neuschwander-Tetri, BA; Portincasa, P; Wang, DQ; Wang, HH | 1 |
| de Bari, O; Liu, M; Paik, CN; Portincasa, P; Wang, DQ; Wang, HH | 1 |
| Frikke-Schmidt, R; Lauridsen, BK; Nordestgaard, BG; Stender, S; Tybjærg-Hansen, A | 1 |
| Kanno, K; Kishikawa, N; Mizooka, M; Sugiyama, A; Tazuma, S; Yokobayashi, K | 1 |
| Floreani, A | 1 |
| Amigo, L; Arrese, M; Azocar, L; Jarufe, N; Lammert, F; Miquel, JF; Molina, H; Nervi, F; Pimentel, F; Zúñiga, S | 1 |
| Ahmed, MH | 1 |
| Bonfrate, L; Di Ciaula, A; Portincasa, P; Wang, DQ; Wang, HH | 1 |
| Ahmed, MH; Byrne, CD | 1 |
| Jiang, ZY; Parini, P; Pramfalk, C | 1 |
| Ganotakis, ES; Lioudaki, E; Mikhailidis, DP | 1 |
| Andrade, JD; Carey, MC; Fox, JG; Kotecha, VR; Xie, M | 1 |
| Gangopadhyay, A; Khadem, S; Moser, JA; Ren, S; Uppal, H; Xie, W; Zhai, Y | 1 |
| Mendez-Sanchez, N; Portincasa, P; Uribe, M; Wang, DQ; Wang, HH | 1 |
6 review(s) available for ezetimibe and Gallstones
| Article | Year |
|---|---|
Recent advances, novel targets and treatments for cholelithiasis; a narrative review.
Topics: Bile; Cholesterol; Ezetimibe; Gallstones; Risk Factors | 2021 |
Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.
Topics: Anticholesteremic Agents; Azetidines; Cholagogues and Choleretics; Cholesterol; Ezetimibe; Gallstones; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Lipid Metabolism; Liver; Ursodeoxycholic Acid | 2013 |
Targets for current pharmacologic therapy in cholesterol gallstone disease.
Topics: Azetidines; Cholesterol; Cholinergic Antagonists; Ezetimibe; Gallstones; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Treatment Outcome | 2010 |
Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events.
Topics: Anticholesteremic Agents; Atherosclerosis; Azetidines; Cholesterol, LDL; Clinical Trials as Topic; Ezetimibe; Fatty Liver; Female; Gallstones; Humans; Intestinal Absorption; Male | 2010 |
Hepatic Niemann-Pick C1-like 1.
Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Ezetimibe; Fatty Liver; Gallstones; Gene Expression; Gene Expression Regulation; Humans; Intestinal Mucosa; Intestines; Liver; Membrane Proteins; Membrane Transport Proteins | 2011 |
Lipid lowering drugs and gallstones: a therapeutic option?
Topics: Animals; Anti-Obesity Agents; Anticholesteremic Agents; Azetidines; Ezetimibe; Gallstones; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Risk Factors | 2011 |
1 trial(s) available for ezetimibe and Gallstones
| Article | Year |
|---|---|
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
Topics: Adult; Animals; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Azetidines; Bile; Cholelithiasis; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Ezetimibe; Female; Gallbladder Emptying; Gallstones; Humans; Intestinal Absorption; Lipoproteins; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Middle Aged; RNA, Messenger; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Time Factors | 2008 |
11 other study(ies) available for ezetimibe and Gallstones
| Article | Year |
|---|---|
Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice.
Topics: Animals; Caco-2 Cells; Cholesterol; Diet; Diosgenin; Ezetimibe; Gallstones; Humans; Intestines; Lipopolysaccharides; Liver; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL | 2023 |
Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
Topics: Animals; Anticholesteremic Agents; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Diet; Ezetimibe; Gallbladder; Gallstones; Guinea Pigs; Homeostasis; Hydroxymethylglutaryl CoA Reductases; Hypoglycemic Agents; Liver; Male; Pioglitazone; Sterol Regulatory Element Binding Protein 2 | 2019 |
Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia.
Topics: Animals; Aspirin; Chemoprevention; Cholecystolithiasis; Cholesterol; Cholesterol, Dietary; Chronic Disease; Diet; Disease Models, Animal; Disease Progression; Ezetimibe; Fatty Liver; Feeding Behavior; Gallbladder Neoplasms; Gallstones; Inflammation; Male; Metaplasia; Mice, Inbred C57BL; Precancerous Conditions; Spleen | 2020 |
Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.
Topics: Animals; Anticholesteremic Agents; Azetidines; Bile Acids and Salts; Biliary Tract; Cholesterol; Estradiol; Estrogens; Ezetimibe; Female; Gallstones; Intestinal Absorption; Lipid Metabolism; Male; Mice, Inbred AKR; RNA, Messenger | 2014 |
Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease.
Topics: Aged; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Female; Gallstones; Genetic Variation; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemia; Lipid Metabolism; Male; Membrane Proteins; Membrane Transport Proteins; Mendelian Randomization Analysis; Middle Aged; Myocardial Infarction; Risk Factors; Stroke | 2015 |
Long-term administration of a Niemann-Pick C1-like 1 inhibitor, ezetimibe, does not worsen bile lithogenicity in dyslipidemic patients with hepatobiliary diseases.
Topics: Anticholesteremic Agents; Bile; Cholesterol; Dyslipidemias; Ezetimibe; Fatty Liver; Female; Gallstones; Humans; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Phytosterols; Ursodeoxycholic Acid | 2016 |
A novel approach for prevention and dissolution of cholesterol gallstones.
Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Disease Models, Animal; Ezetimibe; Gallstones; Humans | 2008 |
Ezetimibe prevents cholesterol gallstone formation in mice.
Topics: Animals; Anticholesteremic Agents; Azetidines; CD36 Antigens; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Duodenum; Ezetimibe; Female; Gallstones; Gene Expression; Humans; Intestinal Absorption; Liver; Male; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL | 2008 |
Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.
Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Clinical Trials as Topic; Diet; Drug Evaluation, Preclinical; Ezetimibe; Fatty Liver; Gallstones; Humans; Insulin Resistance; Intestine, Small | 2010 |
Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis.
Topics: Animals; Azetidines; Bile; Bile Acids and Salts; Biological Transport; Cholecystokinin; Cholesterol; Cholic Acid; Diet, High-Fat; Ezetimibe; Female; Gallbladder; Gallstones; Gastrointestinal Transit; Helicobacter hepaticus; Helicobacter Infections; Intestinal Absorption; Intestine, Small; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Sarcolemma; Sterols | 2012 |
Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
Topics: Animals; Anticholesteremic Agents; Azetidines; Bile Acids and Salts; Cholecystitis; Cholesterol; Crystallization; Diet; DNA-Binding Proteins; Ezetimibe; Female; Gallbladder; Gallstones; Gene Expression Profiling; Intestinal Mucosa; Lipid Metabolism; Liver; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Orphan Nuclear Receptors; Phospholipids; Receptors, Cytoplasmic and Nuclear; Receptors, LDL | 2008 |